Diarrhoea is not the only symptom that needs to be treated in patients with microscopic colitis

European Journal of Internal Medicine

Volumn 24, Issue 6, 2013, Pages 573-578

  Roth, Bodil ^a   Bengtsson, Mariette ^b   Ohlsson, Bodil ^a  

^a LUND UNIVERSITY   (Sweden)

^b MALMÖ UNIVERSITY   (Sweden)

Author keywords

Drug treatment; Gastrointestinal symptoms; Irritable bowel syndrome; Life style factors; Microscopic colitis; Psychological well being

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; THYROID HORMONE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; COLLAGENOUS COLITIS; COLON BIOPSY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DRUG EFFECT; FEMALE; GASTROENTEROLOGY; GASTROINTESTINAL SYMPTOM; HUMAN; INDIGESTION; IRRITABLE COLON; LIFESTYLE; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROSCOPIC COLITIS; PHYSICAL ACTIVITY; PSYCHOLOGICAL WELL BEING; RATING SCALE; RISK FACTOR; SMOKING HABIT; SOCIAL ASPECT; WELLBEING;

DRUG TREATMENT; GASTROINTESTINAL SYMPTOMS; IRRITABLE BOWEL SYNDROME; LIFE STYLE FACTORS; MICROSCOPIC COLITIS; PSYCHOLOGICAL WELL-BEING;

ABDOMINAL PAIN; ADRENAL CORTEX HORMONES; ADULT; AGED; ALCOHOL DRINKING; COLITIS, MICROSCOPIC; CONSTIPATION; DIARRHEA; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; PROTON PUMP INHIBITORS; QUALITY OF LIFE; QUESTIONNAIRES; SMOKING; TREATMENT OUTCOME;

EID: 84883558316     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.02.006     Document Type: Article

References (39)

1. M.A. Rasmussen, and L.K. Munck Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease-microscopic colitis? Aliment Pharmacol Ther 36 2012 79 90
2. D.S. Pardi, and C.P. Kelly Microscopic colitis Gastroenterology 140 2011 1155 1165
3. M. Olesen, S. Eriksson, J. Bohr, G. Järnerot, and C. Tysk Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients Gut 53 2004 536 541 (Pubitemid 38372978)
4. F. Fernandez-Banares, A. Salas, M. Forne, M. Esteve, J. Espinós, and J.M. Viver Incidence of collagenous and lymphocytic colitis: a 5-year population-based study Am J Gastroenterol 94 1999 418 423 (Pubitemid 29084662)
5. A. Munch, D. Aust, J. Bohr, O. Bonderup, F. Fernandez-Banares, and H. Hjortswang for the European Microscopic colitis group (EMCG). Microcopic colitis: Current status, present and future challenges J Crohns Colitis 6 2012 932 945
6. H. Hjortswang, C. Tysk, J. Bohr, C. Benoni, L. Vigren, and A. Kilander Health-related quality of life is impaired in active collagenous colitis Dig Liver Dis 43 2011 102 109
7. D. Limsui, D.S. Pardi, M. Camilleri, E.V. Loftus Jr., P.P. Kammer, and W.J. Tremaine Symptomatic overlap between irritable bowel syndrome and microscopic colitis Inflamm Bowel Dis 13 2007 175 181 (Pubitemid 46806226)
8. B. Roth, and B. Ohlsson Gastrointestinal symptoms and psychological well-being in patients with microscopic colitis Scand J Gastroenterol 48 2013 27 34
9. S.W. Carmack, R.H. Lash, J.M. Gulizia, and R.M. Genta Lymphocytic disorders of the gastrointestinal tract: a review for the practicing pathologist Adv Anat Pathol 16 2009 290 306
10. M. Henriksen, J. Jahnsen, I. Lygren, J. Sauar, M.H. Vatn, and B. Moum and the IBSEN study group. Change in diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN study) Scand J Gastroenterol 41 2006 1037 1043
11. M. Simrén, H. Abrahamsson, J. Svedlund, and E.S. Björnsson Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern Scand J Gastroenterol 36 2001 545 552 (Pubitemid 32328447)
12. P.J. Boekema, E.F. van Dam van Isselt, M.L. Bots, and A.J. Smout Functional bowel symptoms in a general Dutch population and associations with common stimulants Neth J Med 59 2001 23 30 (Pubitemid 32618644)
13. S.H. Kang, S.W. Choi, S.J. Lee, W.S. Chung, H.R. Lee, and K.Y. Chung The effects of lifestyle modification on symptoms and quality of life in patients with irritable bowel syndrome: a prospective observational study Gut Liver 5 2011 472 477
14. T. Luntamo, A. Sourander, M. Rihko, M. Aromaa, H. Helenius, and M. Koskelainen Psychosocial determinants of headache, abdominal pain, and sleep problems in a community sample of Finnish adolescents Eur Child Adolesc Psychiatry 21 2012 301 313
15. E.F. Yen, B. Pokhrel, H. Du, S. New, L. Bianchi, and B. Witt Current and past cigarette smoking significantly increase risk for microscopic colitis Inflamm Bowel Dis 18 2012 1835 1841
16. L. Lissner, A. Sjöberg, M. Schütze, L. Lapidus, L. Hulthén, and C. Björkelund Diet, obesity and obesogenic trends in two generations of Swedish women Eur J Nutr 47 2008 424 431
17. F. Caputo, T. Vignoli, L. Leggio, G. Addolorato, G. Zoli, and M. Bernardi Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options Exp Gerontol 47 2012 411 416
18. J. Svedlund, I. Sjödin, and G. Dotevall GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease Dig Dis Sci 33 1988 129 134 (Pubitemid 18054672)
19. E. Dimenäs, H. Glise, B. Hallerbäck, H. Hernqvist, J. Svedlund, and I. Wiklund Quality of life in patients with upper gastrointestinal symptoms: an improved evaluation of treatment regimens? Scand J Gastroenterol 28 1993 681 687 (Pubitemid 23231987)
20. E. Dimenäs, H. Glise, B. Hallerbäck, H. Hernqvist, J. Svedlund, and I. Wiklund Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer Scand J Gastroenterol 30 1995 1046 1052
21. E. Dimenäs, G. Carlsson, H. Glise, B. Israelsson, and I. Wiklund Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease Scand J Gastroenterol 31 1996 8 13 (Pubitemid 27023576)
22. H. Dupy The psychological general well-being (PGWB) index N.K. Wenger, M.E. Mattson, C.F. Furberg, J. Elinson, Assessment of quality of life in clinical trails of cardiovascular therapies 1984 Le Jacq Publishing New York
23. D.A. Drossman, E. Corrazziari, M. Delvaux, R. Spiller, N.J. Talley, and W.G. Thompson Rome III: The Functional Gastrointestinal Disorders 2006 Degnon Associates McLean, VA
24. www.regeringen.ax/./Mini-intervention-for-primarvarden.pdf
25. N.J. Talley Irritable bowel syndrome Intern Med J 36 2006 724 728 (Pubitemid 44563434)
26. I. Mizyed, S.S. Fass, and R. Fass Review article: gastro-oesophageal reflux disease and psychological comorbidity Aliment Pharmacol Ther 29 2009 351 358
27. S.D. Parry, J.R. Barton, and M.R. Welfare Factors associated with the development of post-infectious functional gastrointestinal diseases: does smoking play a role? Eur J Gastroenterol Hepatol 17 2005 1071 1075 (Pubitemid 41424000)
28. Y. Fujiwara, M. Kubo, Y. Kohata, H. Machida, H. Okazaki, and H. Yamagami Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome Intern Med 50 2011 2443 2447
29. C. Pisinger, M. Aadahl, U. Toft, H. Birke, J. Zytphen-Adeler, and T. Jørgensen The association between active and passive smoking and frequent pain in a general population Eur J Pain 15 2011 77 83
30. A. Keshavarzian, A. Farhadi, C.B. Forsyth, J. Rangan, S. Jakate, and M. Shaikh Eidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats J Hepatol 50 2009 538 547
31. E. Mutlu, A. Keshavarzian, P. Engen, C.B. Forsyth, M. Sikaroodi, and P. Gillevet Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats Alcohol Clin Exp Res 33 2009 1836 1846
32. A. Banan, J.Z. Fields, H. Decker, Y. Zhang, and A. Keshavarzian Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction J Pharmacol Exp Ther 294 2000 997 1008 (Pubitemid 30666852)
33. A. Banan, A. Keshavarzian, L. Zhang, M. Shaikh, C.B. Forsyth, and Y. Tang NF-kappaB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium Alcohol 41 2007 447 460 (Pubitemid 47554481)
34. T.A. Miller, G.S. Smith, A. Banan, and E.R. Kokoska Cytoskeleton as a target for injury in damaged intestinal epithelium Microsc Res Tech 51 2000 149 155
35. M.C. Andrade, N.M. Vaz, and A.M. Faria Ethanol-induced colitis prevents oral tolerance induction in mice Braz J Med Biol Res 36 2003 1227 1232 (Pubitemid 37236248)
36. G.R. Swanson, S. Sedghi, A. Farhadi, and A. Keshavarzian Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease Alcohol 44 2010 223 228
37. M.I. Queipo-Ortuño, M. Boto-Ordóñez, M. Murri, J.M. Gomez-Zumaquero, M. Clemente-Postigo, and R. Estruch Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers Am J Clin Nutr 95 2012 1323 1334
38. G. Chiva-Blanch, M. Urpi-Sarda, R. Llorach, M. Rotches-Ribalta, M. Guillén, and R. Casas Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial Am J Clin Nutr 95 2012 326 334
39. U. Grittner, S. Kuntsche, G. Gmel, and K. Bloomfield Alcohol consumption and social inequality at the individual and country levels - results from an international study Eur J Public Health 2012 May 4 [Epub ahead of print]